# Novartis Pharma Stein AG - Inspection Records Source: https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b > Inspection records and compliance data for Novartis Pharma Stein AG in Stein Ag, None. Access full analysis and detailed observations. --- ## Details - Name: Novartis Pharma Stein AG - FEI Number: 3002653483 - City: Stein Ag - State: None - Country Name: Switzerland - Address Line 1: Schaffhauserstrasse 101 - Zip Code: None - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [FDA Inspection 1230809 - Novartis Pharma Stein AG - 2023-11-20](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/161d111e-4fc5-4071-9a22-adb475a24dd0) — source: FDA, date: November 20, 2023 - [483 - Novartis Pharma Stein AG - 2022-12-06](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/50585e29-a34c-4320-aca5-c3193ba50374) — source: FDA, date: December 6, 2022 - [483 - Novartis Pharma Stein AG - 2022-12-06](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/e63a23c8-caec-4d2b-9ed3-27a499bfdb25) — source: FDA, date: December 6, 2022 - [FDA Inspection 1192104 - Novartis Pharma Stein AG - 2022-12-06](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/5994d6f5-291c-4a32-87bf-4376f992a6bb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2022 - [483 - Novartis Pharma Stein AG - 2018-12-04](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/3e713a20-3bd1-4991-aad5-bac1eccc2725) — source: FDA, date: December 4, 2018 - [FDA Inspection 1073408 - Novartis Pharma Stein AG - 2018-12-04](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/3f2284e9-7b71-4b40-a3f0-ac4686b89e80) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 4, 2018 - [483 - Novartis Pharma Stein AG - 2018-09-21](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/7b770256-872c-467d-b840-a8336bd5c659) — source: FDA, date: September 21, 2018 - [483 - Novartis Pharma Stein AG - 2017-05-09](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/744bc0b9-9ae9-4b95-8ef6-c6abe8b8f1c6) — source: FDA, date: May 9, 2017 - [FDA Inspection 1015468 - Novartis Pharma Stein AG - 2017-05-09](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/41e9858b-8978-450a-9e2b-657833e31ff4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 9, 2017 - [FDA Inspection 947993 - Novartis Pharma Stein AG - 2015-10-16](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/6aecea73-0741-4c95-b1cf-6aedfc498659) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2015 - [FDA Inspection 924507 - Novartis Pharma Stein AG - 2015-05-01](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/c4877126-7aef-4183-bd25-589a52fba74d) — classification: No Action Indicated (NAI), source: FDA, date: May 1, 2015 - [FDA Inspection 875305 - Novartis Pharma Stein AG - 2014-03-25](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/3304c33b-5488-4124-9d1d-9e645a816ed5) — classification: No Action Indicated (NAI), source: FDA, date: March 25, 2014 - [FDA Inspection 875305 - Novartis Pharma Stein AG - 2014-03-25](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/6894d4cd-3775-4701-bfbb-ced0311aec69) — classification: No Action Indicated (NAI), source: FDA, date: March 25, 2014 - [FDA Inspection 791807 - Novartis Pharma Stein AG - 2012-06-22](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/8ac5186e-490b-4203-92f2-5088421c6033) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 22, 2012 - [FDA Inspection 672681 - Novartis Pharma Stein AG - 2010-07-02](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/05f49b75-8ef7-4a5d-89fb-ba4f8a35901e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 2, 2010 ## Related Companies - [Patheon Pharmaceuticals Inc.](https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b) - [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f) - [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70) - [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf) - [Latina Pharma S.p.A.](https://www.keypedia.com/companies/latina-pharma-spa/9cb7e758-39a0-4b4c-bfad-93d1468f5d38) - [Ferring Microbiome Inc.](https://www.keypedia.com/companies/ferring-microbiome-inc/860d4130-d93a-4017-97ca-30033280de85) - [Baxalta Belgium Manufacturing SA](https://www.keypedia.com/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9) - [Nordmark Arzneimittel GMBH & Co. KG](https://www.keypedia.com/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b) - [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63) - [Changzhou Pharmaceutical Factory](https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4) ## Related Officers - [investigator](https://www.keypedia.com/people/don-h-bark/c91b02bc-f735-46d8-a0ef-b44724868908) - [Ademola O. Daramola](https://www.keypedia.com/people/ademola-o-daramola/814113a4-38bc-4ce5-b6af-09c7e688c0ec) - [Senior Regulatory Specialist](https://www.keypedia.com/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942) - [Anjali Shukla](https://www.keypedia.com/people/anjali-shukla/23e50484-91bf-436f-971e-2efd3c2b3d0a) - [Travis S. Bradley](https://www.keypedia.com/people/travis-s-bradley/4d7756cb-65fd-4bd6-be24-25710668e6d8) - [CSO](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)